Search
for
Sort by
Research 241–270 of 844
- A REVIEW ON PHYTOCONSTITUENTS AND PHARMACOLOGICAL PROPERTIES OF SANSEVIERIA TRIFASCIATA (Snake Plant)
- Standardization of Sphagneticola calendulacea (L.) Pruski. Stem
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
- Treatment of invasive aspergillosis with itraconazole
- The Rotterdam Study: 2016 objectives and design update
- Bioactivities, isolation and purification methods of polysaccharides from natural products: A review
- Severe cutaneous adverse reactions to drugs
- Is COVID-19 Gender-sensitive?
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Cutaneous signs in COVID ‐19 patients: A review
- The pharmacology of methotrexate
- Ancient-modern concordance in Ayurvedic plants: some examples.
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Interferon in the treatment of cutaneous T-cell lymphoma
- Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up
- Polycystic Ovary Syndrome
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- <i>Hedychium spicatum</i>: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Skin manifestations among<i>GATA2</i>-deficient patients
- Idiopathic CD4+ T-lymphocytopenia